TSXV:NSP.H - Post by User
Post by
G1945Von Oct 30, 2020 6:06pm
544 Views
Post# 31817298
Cavaltinib - Cytokines
Cavaltinib - CytokinesThis Cavaltinib treatment for COVID-19 will be needed for years to come with and without a vaccine.
Few ways that you can develop an antibody to combat COVID 19. One is an antibody taken from a patient with covid-19 who actually recovered, and the other one is manufactured in the lab.
Now, if you look back some of how somebody gets at that point, your immune tries to kick in and develop antibodies. The theory is if you get patients that regenerate antibodies when they have mild symptoms, it really helps. Your immune system sort of kick in and fight the infection. However, when patients develop severe symptoms when they're incubated or in the ICU, there is this cytokine response when your immune system goes into a sort of overdrive. At that point, the antibodies really don't seem to help. A lot of patients actually die from the cytokine response.
The studies with "Regeneron" and antibodies of that nature have shown to really benefit when you have mild symptoms and not severe symptoms or patients on oxygen therapy or who are being incubated. Cavaltinib will help to calm the cytokine storm. This treatment will be needed for years to come.
Naturally Splended needs to get the show on the road ASAP.
G1945V